More States Demand Notification to Use Biosimilar Drugs

  • March 30, 2015
The FDA’s first approval of a biosimilar drug is prompting more states to consider requiring patients and doctors to be notified when generic imitations of biological drugs are substituted for name brands. Read More


Number of states still collecting less tax revenue than they did before their receipts plunged during the Great Recession, after adjusting for inflation.

Learn more at Pew’s Fiscal 50

About Stateline

Stateline covers issues that are key to state policy: health care, demographics, the business of government, and fiscal issues.

Learn more